About RxWare
RxWare is a company based in Wilmington (United States) founded in 2013 by Yishai Knobel. RxWare has raised $12.69 million across 4 funding rounds from investors including IQVIA, PharMedQuest and Windham Capital Partners. RxWare offers products and services including High Response Surveys, Quick Consent Capture, Optimized Copay Workflow, and RxConvo Wraparound Solution. RxWare operates in a competitive market with competitors including Autolomous, Conformia Software, InstantGMP, QbDVision and Skyland Analytics, among others.
- Headquarter Wilmington, United States
- Founders Yishai Knobel
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$12.69 M (USD)
in 4 rounds
-
Latest Funding Round
$6.14 M (USD), Series A
Aug 01, 2025
-
Investors
IQVIA
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of RxWare
RxWare offers a comprehensive portfolio of products and services, including High Response Surveys, Quick Consent Capture, Optimized Copay Workflow, and RxConvo Wraparound Solution.
Platform for gathering patient feedback to improve satisfaction.
Tool for electronic patient consent to facilitate therapy enrollment.
System to streamline copay processes and enhance therapy access.
Service for comprehensive patient support throughout prescription journeys.
People of RxWare
Unlock access to complete
Funding Insights of RxWare
RxWare has successfully raised a total of $12.69M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $6.14 million completed in August 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in RxWare
RxWare has secured backing from 5 investors, including institutional and angel investors. Prominent investors backing the company include IQVIA, PharMedQuest and Windham Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Clinical research and commercialization solutions are provided for healthcare.
|
Locked | Locked | Locked | |
|
Windham Capital Partners is focused on HealthTech venture investments.
|
Locked | Locked | Locked | |
|
Medical benefit management for specialty healthcare is developed.
|
Locked | Locked | Locked |
Investor details for RxWare
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by RxWare
Investment portfolio details for RxWare
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - RxWare
Detailed financials for RxWare
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Rxware Comparisons
Peer comparison for RxWare
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of RxWare
RxWare operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Autolomous, Conformia Software, InstantGMP, QbDVision and Skyland Analytics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Software solutions are developed for cell therapy manufacturers.
|
|
| Locked | Locked | Locked |
Product lifecycle management software is provided for life sciences industries.
|
|
| Locked | Locked | Locked |
Manufacturing and operation solutions for life sciences industries are provided.
|
|
| Locked | Locked | Locked |
A platform for process management in pharmaceutical manufacturing is provided.
|
|
| Locked | Locked | Locked |
Data management and analytics solutions are provided for life sciences.
|
Detailed competitors of RxWare
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Rxware
Complete news archive for RxWare
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about RxWare
RxWare was founded in 2013 and raised its 1st funding round 1 year after it was founded.
RxWare is headquartered in Wilmington, United States. It is registered at Wilmington, Delaware, United States.
Yishai Knobel is the current CEO of RxWare. They have also founded this company.
RxWare is a funded company, having raised a total of $12.69M across 4 funding rounds to date.
RxWare was founded in 2013 and is headquartered in Wilmington, United States. Operations focus on the manufacturing sector, where software solutions are developed to handle production processes, inventory control, and workflow optimization. Services include tools for real-time monitoring and data analytics tailored to industrial needs. The company serves clients across various manufacturing subsectors, emphasizing efficiency in operational management.
RxWare's top competitors include QbDVision, InstantGMP and Conformia Software.
RxWare offers High Response Surveys, Quick Consent Capture, Optimized Copay Workflow, and RxConvo Wraparound Solution.
RxWare has 5 investors. Key investors include IQVIA, PharMedQuest, Windham Capital Partners, Walter Winshall, and Robert Oringer.